Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

IMVT holding history

Immunovant, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings

Shares (Q2 2026)
472,122
Value
$18.2M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of IMVT by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026472,122$18.2M<0.1%−212,429−31.0%ReducedHolders
Q1 2026684,551$17.0M<0.1%−47,835−6.5%ReducedHolders
Q4 2025732,386$18.6M<0.1%+6,213+0.9%AddedHolders
Q3 2025726,173$11.7M<0.1%+54,889+8.2%AddedHolders
Q2 2025671,284$10.7M<0.1%−60,569−8.3%ReducedHolders
Q1 2025731,853$12.5M<0.1%+141,089+23.9%AddedHolders
Q4 2024590,764$14.6M<0.1%+449,775+319.0%AddedHolders
Q3 2024140,989$4.02M<0.1%+21,634+18.1%AddedHolders
Q2 2024119,355$3.15M<0.1%−83,195−41.1%ReducedHolders
Q1 2024202,550$6.54M<0.1%+47,468+30.6%AddedHolders
Q4 2023155,082$6.53M<0.1%+70,285+82.9%AddedHolders
Q3 202384,797$3.26M<0.1%−7,138−7.8%ReducedHolders
Q2 202391,935$1.74M<0.1%−31,101−25.3%ReducedHolders
Q1 2023123,036$1.91M<0.1%−30,839−20.0%ReducedHolders
Q4 2022153,875$2.73M<0.1%+146,897+2,105.1%AddedHolders
Q3 20226,978$39.0K<0.1%+4,695+205.7%AddedHolders
Q2 20222,283$9.00K<0.1%+2,283NewHolders
Q1 20220$00.0%−166,534−100.0%Sold outHolders
Q4 2021166,534$1.42M<0.1%+117,796+241.7%AddedHolders
Q3 202148,738$423.0K<0.1%+12,095+33.0%AddedHolders
Q2 202136,643$387.0K<0.1%−46,487−55.9%ReducedHolders
Q1 202183,130$1.33M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.